BioNTech SE announced the launch of its Malaria project, which aims to develop a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply […]
Search Results for vaccin
TWINCORE researchers give hope to people with autoimmune diseases such as rheumatoid arthritis or multiple sclerosis that they too will soon be able to be vaccinated against COVID-19.
Rokote Laboratories Finland Ltd. has secured total of nine million euros of funding for the development of a coronavirus vaccine to be administered as a […]
Doctors at the Tübingen University Hospital in Germany have developed a vaccine against SARS-CoV-2 specifically designed for patients with cancer or an immune deficiency
A study at Saarland University has shown that a combination with active ingredients from Astrazeneca and Biontech/Pfizer appears to be the best combination.
Data journalist Jelmer Visser crosses borders every week with his map-coloring skills and data visualizations in his Corona in Europe column: This week: Talk is cheap, actions speak louder than words.
Data journalist Jelmer Visser sheds light on the corona crisis on a European level with maps and visualizations: despite the inevitable third wave, is there light at the end of the tunnel?
Data journalist Jelmer Visser sheds light on the corona crisis across Europe each week with maps and visualizations: this week, vaccination passports.
Data journalist Jelmer Visser makes real-world sense of the corona pandemic in Europe. This week: How did the British, Americans and Israelis come by so many vaccines?
elmer Visser outlines the spread of the corona pandemic in Europe for Innovation Origins. This week: Why the British are vaccinating at full speed and EU countries aren’t.
Jelmer Visser interprets for Innovation Origins the spread of the corona pandemic in Europe. This week: Where are countries one month after V Day?
Jelmer Visser tracks for Innovation Origins the movements of the coronary pandemic in Europe. This week: which countries score best (and worst) in vaccinating their population?
Twenty percent of the Dutch population does not want to take the corona vaccine out of a fear of needles. AINAR offers a solution in the form of a game app.
The vaccine from Pfizer and BioNTech is 90 percent effective. Today, the companies announced the preliminary results of their phase three trials.
The Belgian company Janssen is starting the final phase of their vaccine research in the United States, South Africa and South America. The Netherlands will also have its turn soon.
Wild mice resemble humans more than lab mice – and that’s a big deal for those working on a Corona vaccine
Experiments on lab mice often yield wrong results, so wild mice are being added to the mix for greater accuracy
The vaccine against COVID-19 is designed to enter the cells via the same route as the virus - and thereby activate the immune system.
The German Paul Ehrlich Institute (PEI) is confident that a vaccine against the novel SARS CoV-2 coronavirus could be available by the end of 2020.
Study: existing tuberculosis vaccine is safe, stimulates the immune system, and may also be effective against COVID-19
The data show "a cautiously positive picture", with a lower number of patients among the vaccinated group, as well as less fatigue symptoms.
"Together, we have an opportunity to make a difference in the lives of patients at this time of great need."